GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $27,969,000 | -60.8% | 211,869 | -69.9% | 0.17% | -62.9% |
| Q3 2017 | $71,434,000 | -18.4% | 703,856 | -19.4% | 0.46% | -21.5% |
| Q2 2017 | $87,549,000 | -13.3% | 873,308 | +4.6% | 0.59% | +32.3% |
| Q1 2017 | $100,937,000 | -0.8% | 834,605 | -8.4% | 0.45% | -3.7% |
| Q4 2016 | $101,785,000 | -22.0% | 910,831 | -7.3% | 0.46% | -17.8% |
| Q3 2016 | $130,428,000 | +71.3% | 982,655 | +18.2% | 0.56% | +74.3% |
| Q2 2016 | $76,145,000 | – | 831,547 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |